Real-World Switching and Discontinuation Patterns for Biologic Disease-Modifying Antirheumatic Drugs in Patients with Active Psoriatic Arthritis in Japan
{{output}}
ObjectivesTo evaluate switching and discontinuation of biologic disease-modifying antirheumatic drugs (bDMARDs) among psoriatic arthritis (PsA) patients in Japan over 12 months. MethodsClaims data from the Japan Medical Data Centre (1/2005-10/2023) were analys... ...
